Stock Market & Financial News
CellaVision AB (publ) (CLVSF) Q2 2026 Earnings Call Transcript
CellaVision AB (publ) (CLVSF) Q2 2026 Earnings Call Transcript
CLVSF Hyperliquid Price Faces $55 Risk After $59M Whale Transfers
Suspected institutional wallets move millions in HYPE to exchanges as liquidations and bearish technical signals pressure key support.
Antero Resources Is in Play: Which Energy Titan Will Acquire It?
Antero Resources (NYSE:AR | AR Price Prediction) has quietly become one of the most strategically attractive assets in U.S.
AR Travelers Earnings Beat Estimates. Does It Prove Recent Downgrades Wrong?
Travelers reported adjusted earnings well above the Wall Street view.
TRV 
GBP/USD Price Forecast: British Pound extends weakness in process of UK leadership change
GBP/USD Price Forecast: British Pound extends weakness in process of UK leadership change
Intuitive Surgical stock sinks despite earnings beat on 2026 procedure growth outlook
Shares of Intuitive Surgical tumbled about 12% in premarket trading on Friday after the robotic surgery company issued a full-year procedure growth outlook that fell short of investor expectations, overshadowing stronger-than-expected second-quarter earnings and revenue. The maker of the da Vinci robotic surgery platform reported adjusted earnings of $2.80 per share for the quarter, comfortably ahead of analysts' estimates of $2.51.
ISRG 
AUD/CAD: Months of Indecision — Is a Breakout Finally Coming?
The Australian dollar has clawed back most of its end-of-June losses, when it touched three-month lows against the greenback amid escalating Middle East tensions. Since then, sentiment has improved: the RBA's Assistant Governor Sarah Hunter signalled the board stands ready to tighten further if the recent oil shock feeds into inflation expectations.
The VIX Futures Curve Signal That Could Cut SVOL's Yield in Half
The Simplify Volatility Premium ETF (NYSEARCA:SVOL) has quietly done its job in 2026: shares sit at $16, up 3% year-to-date and 14% over the past 12 months, while still pushing out roughly $0.28 a month in distributions.
SVOL 
Gold Probes Again Through Key $4000 Support
Gold trades below $4000 level on Friday following Thursday's break and daily close below this level (the first close well below the mark since 6 November 2025), after the price moved around 4K for almost one month, but all attacks failed to register a clear break lower.
U.S.-China AI feud sees ASML walk tightrope between sales and geopolitics
China will contribute around 20% of ASML's revenue across the whole of 2026, the company's CFO said. While that figure is a sizable drop from previous years, political headwinds in the U.S. are pushing for stricter export controls on sales of chipmaking hardware to Beijing.
ASML 
Here's What Can End Micron's Stock Pain
Micron stock is down 25% in the past month and has fallen below $1 trillion but there is hope on the horizon.
MU 
American bank says Ryanair's share price weakness has run too far
Citi has argued that Ryanair Holdings PLC's (LSE:RYA) recent underperformance against Europe's legacy airlines is overdone and looks set to reverse. The bank said shares in the Irish low-cost carrier have lagged those of its full-service European peers by around 15 percentage points so far this year.
RYAAY 
Strength Seen in GrafTech (EAF): Can Its 7.9% Jump Turn into More Strength?
GrafTech (EAF) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
EAF 
NASDAQ futures tumble as chip rout deepens, dragging Bitcoin along for the ride
Nasdaq 100 futures fell roughly 2% as semiconductor stocks sold off on AI valuation doubts. Bitcoin dropped in tandem, highlighting persistent crypto-tech NASDAQ futures tumble as chip rout deepens, dragging Bitcoin along for the ride.
Webull: Why The Bear Case Is Louder Than It Should Be
Webull has been upgraded from Hold to Buy after a 35% stock decline and notable multiple compression. BULL's consistent revenue beats since IPO reinforce confidence in management and the company's growth trajectory. Despite not being the cheapest, BULL's valuation appears justified if top- and bottom-line growth persists.
BULL 
EUR/USD Subdued by Data: Chances of Fed Rate Hike Diminish
Weaker-than-expected US inflation data led markets to scale back expectations of an imminent Federal Reserve rate hike. At the same time, escalating US-Iran tensions continue to sustain inflationary concerns.
RSPS: Consumer Staples Dashboard For July
The beverage industry is significantly undervalued versus historical averages, while tobacco and retail are overvalued. RSPS offers consumer staples exposure with better value and less company-specific risk than XLP, but also lower risk-adjusted returns and trading volumes. Four stocks are cheaper than their peers in July.
RSPS 
FXZ: Materials Dashboard For July
The materials sector appears notably overvalued, with the mining/metals and chemicals industries trading 30%+ above historical valuation baselines. The First Trust Materials AlphaDEX Fund ETF offers materials sector exposure with lower company-specific risk and a value tilt versus XLB. FXZ has outperformed XLB by 1.6% annualized since 2007 and by 17.5% over the last 12 months.
FXZ 
Why Is HyperLiquid (HYPE) Price Crashing? Is This a Short-Term Capitulation?
HyperLiquid (HYPE) price has corrected nearly 20% from its recent high near $69, slipping back toward the $60 mark despite what initially appeared to be a bullish regulatory development. Earlier this week, the Hyperliquid Policy Center and Sullivan & Cromwell LLP met with the U.S.
Across Protocol confirms Solana bridge attack, says user funds are safe
Across Protocol confirmed an attack on its Solana bridge deployment, disabling deposits while assuring users their funds remain safe and unaffected. Across Protocol confirms Solana bridge attack, says user funds are safe.
BTC Wobbles Near $64K As Middle East Drama Cranks Up
BTC's capped in a tight range amid Strait of Hormuz drama, but liquidations are piling up at a sensitive level.
PayPal Board Calls $53 Billion Stripe-Advent Bid Inadequate
PayPal's board believes the $53 billion takeover offer from Stripe and Advent International offered on July 15 undervalues the company. According to a report from Reuters, the development could potentially open negotiations over price, deal structure and regulatory risk.
PYPL 
Lamar Advertising: The Market Has Finally Caught Up To Its True Potential (Downgrade)
Lamar Advertising Company is downgraded to Hold as its current price now reflects fair value after a 42% return since the last Buy rating. LAMR's digital billboard pivot and accretive M&A drive strong AFFO growth potential, with 2026 guidance at $8.50–$8.70 per share supporting a 74% dividend payout ratio. Digital billboards pivot to offer significant potential to transform into the industry's next stage, although macro headwinds could pressure near-term advertising budgets and consumers.
TCPFF 
POSCO Holdings: Encouraging Investor Event Takeaways
POSCO Holdings Inc. remains a 'Buy' based on my assessment of its Investor Day disclosures. At the recent investor event, it reiterated a turnaround of its Argentinian lithium business and consistent shareholder distributions, similar to its 1Q26 call remarks. Management aims to fully close the stock's NAV discount by FY2028, with portfolio reorganization and listed subsidiary stake reduction initiatives.
PKX 
Why Gold Can't Rally Even with Softer Inflation Data
Gold slips even as U.S. inflation data cools, with oil prices climbing on renewed Iran tensions and the dollar regaining strength. FOREX.com Market Analyst Fawad Razaqzada breaks down why the Fed needs more than one soft inflation print, plus the key gold technical levels to watch next.
‘It's Getting Close to as Good as It Gets': Jamie Dimon Just Posted Record Profits, and Warned It Feels Like 2007
Jamie Dimon just delivered a JPMorgan earnings report for the record books, and in the same breath told everyone to enjoy it while it lasts.
JPM 
Live markets: Bitcoin slips to $63,000 as the chip rout goes global
A deepening global selloff in chipmakers dragged risk assets lower, pulling bitcoin back from the $65,000 it reached on this week's soft inflation print.
Inhibrx Biosciences: The Rare Disease Launch Is Only The Opening Act
Inhibrx is transitioning from a platform to a clinical-stage biotech, with ozekibart and INBRX-106 as key value drivers. Ozekibart's BLA for chondrosarcoma is under FDA review with an April 14, 2027 PDUFA date, supported by strong PFS and disease control data. INBRX-106 shows promising early efficacy as a PD-1 enhancer in HNSCC, with pivotal PFS data expected in Q4 2026 and Phase 3 initiation in Q3 2026.
PFS 
Resolution Minerals secures FAST-41 status for Golden Gate tungsten-gold project
Resolution Minerals Ltd (ASX:RML, OTCQB:RLMLF, FRA:NC3) has secured US Federal FAST-41 Transparency coverage for its Golden Gate tungsten-gold target in...
ARM 
Bitcoin Japan Unveils $59.5M Funding Round to Build BTC Treasury Reserve
Bitcoin Japan has unveiled a comprehensive financing strategy targeting approximately 9.66 billion yen, equivalent to roughly $59.5 million in fresh capital. This fundraising round earmarks 662 million yen specifically for the company's inaugural Bitcoin treasury acquisition following its strategic corporate transformation.
